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1282Objective: This study is to discuss a surgical approach for ideal and safe resection of atrial myxoma using the da
Vinci S Surgical System (Intuitive Surgical, Inc, Sunnyvale, Calif).
Methods:Nineteen consecutive patients underwent resection of atrial myxomas with the da Vinci S Surgical Sys-
tem. Mean age of the patients was 46  16 years. Mean tumor size was 453 5.5 cm. Fifteen tumors were in the
left atrium, of which 11 tumors arose from the interatrial septum, 2 from the posterocaudal wall, 1 from the root of
the anterior leaflet of the mitral valve, and 1 from the left atrial roof. In 13 patients, exploration was conducted
through a left atriotomy anterior to the pulmonary veins and excision was achieved by dissecting a plane through
the atrial muscle at the point of attachment. In the first 2 patients, exploration and excision were conducted
through an oblique right atriotomy. Four tumors were in right atrium, all of which were resected from the beating
heart. The da Vinci instrument arms were inserted through three 1-cm trocar incisions in the right side of the chest.
Via 4 port incisions and a 1.5-cm working port, all the procedures were completed with a 30 angled endoscope
facing upward with the da Vinci S robot.
Results:Resection was successful in all patients. There were no operative deaths, strokes, or other complications.
All the patients were discharged. No recurrences of tumor or septal leakage were found in the complete 1- to
18-month follow-up.
Conclusions: The excision of atrial myxomas with the da Vinci S Surgical System is feasible, efficacious, and
safe. Surgical results are excellent. (J Thorac Cardiovasc Surg 2010;139:1282-5)Traditionally, left atrial myxomas have been resected by me-
dian sternotomy with cardiopulmonary bypass (CPB). Re-
cent advances in robotic instrumentation have facilitated
endoscopic intracardiac procedure.1-7 For example, the atrial
retractor (Intuitive Surgical, Inc, Sunnyvale, Calif) is an ex-
cellent device for atrial exposure, and transthoracic aortic
crossclamps developed by Chitwood, Elbeery, and Moran4
enabled central aortic occlusion without the use of an in-
tra-aortic balloon. However, whether the da Vinci S Surgical
System (Intuitive) could achieve good exposure and ideal re-
section of left or right atrial myxomas remained obscure.
Since January 2007, using the da Vinci S Surgical Sys-
tem, we8-11 have performed more than 200 robotic cardiac
operations, in which robotic resection of left or right atrial
myxomas has been performed on 19 consecutive patients.
In the present article, we intend to address the related issues
on the ideal resection of left or right atrial myxoma to eval-e Minimally Invasive and Robotic Cardiac Surgery Center, Department of
ovascular Surgery, PLA General Hospital, Beijing, China.
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The Journal of Thoracic and Cardiovascular Suruate the safety and efficacy of the procedure using robotic
technology.PATIENTS AND METHODS
Between January 2007 and June 2009, 19 consecutive patients (13 fe-
male and 6 male) underwent resection of left or right atrial myxomas with
the da Vinci S Surgical System with approval from the Institutional Review
Board of PLA General Hospital and informed consent. Mean age of the pa-
tients was 46 16 years (range, 23–58 years), and atrial myxoma was con-
firmed echocardiographically in all patients. Mean weight was 64 10.1 kg
(range, 48–74 kg). The mean tumor size was 453 6.0 11.5 cm (233 46
to 43 3 74 cm). Attachment sites of tumors were as follows: 11 left atrial
tumors arose from the interatrial septum, 2 from the posterocaudal wall, 1
from the root of anterior leaflet of the mitral valve, and 1 from the left atrial
roof. Four myxomas were located in the right atrium. All patients underwent
a history and physical examination followed by a chest radiograph and
transthoracic echocardiogram.
After induction of general anesthesia, all patients were intubated for sin-
gle-lung ventilation. A transesophageal echocardiography (TEE) probe and
arterial pressure monitoring line were inserted. Both a central venous cath-
eter and a 15F venous drainage cannula were placed percutaneously into the
right internal jugular vein. External defibrillator patches were placed to sub-
tend the maximum cardiac mass. Each patient was positioned with the right
side of the chest elevated approximately 30 and with the right arm tucked at
the side. Femoral arterial (18F or 20F) and venous cannulation (21F or 23F)
(Medtronic, Inc, Minnneapolis, Minn) were performed through a 2-cm
transverse right groin incision cutdown with the Seldinger guidewire
method and TEE guidance. Bicaval venous drainage was instituted through
the jugular and femoral/inferior vena cava cannulas.
The camera cannula was placed in the right, 2 to 3 cm lateral to the nipple
in the fourth ICS. A 1.5-cm incision was used as a working port in the same
ICS for the patient-side surgeon (Figure 1). The da Vinci instrument arms
were inserted through three 1-cm trocar incisions in the right side of the
chest. The right instrument arm generally was positioned 4- to 6-cm lateralgery c May 2010
FIGURE 1. Setup of the da Vinci S Surgical System.
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
ICS ¼ intercostal space
TEE ¼ transesophageal echocardiography
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medial and cephalad to the right arm in the second or third ICS. The fourth
arm trocar was placed in the midclavicular line in the fifth ICS (Figure 1).
All resections of myxomas and the atrial closures were completed with
the da Vinci S robot.
CPB was initiated with kinetically assisted bicaval venous drainage. The
aortic occlusion was performed with a Chitwood crossclamp (Scanlan Inter-
national, Inc, Minneapolis, Minn) via the midaxillary line in the fourth ICS.
Antegrade cold blood cardioplegic solution was administered directly
through the anterior chest (second ICS) with a 14F angiocatheter, by which
deairing was done and repeat doses could be given when necessary. TEE
was used routinely to assist deairing. Carbon dioxide was insufflated contin-
uously into the operative field for air displacement.
After the pericardium was opened, stay sutures were placed low on the
pericardium on the right side to rotate the heart for optimal exposure of
the left atrium. A left atriotomy was performed and exposure of left atrial
myxomas was maximized with the atrial retractor (Intuitive; Figure 2). In
13 patients with left atrial myxomas, exploration was conducted through
a left atriotomy anterior to the pulmonary veins. Total excisionwas achieved
by dissecting a plane through the atrial muscle at the point of attachment
(Figures 2 and 3). In the first 2 patients with left atrial tumors attached to
the interatrial septum, exploration was through an oblique right atriotomy.
The point of attachment of the tumor was identified by the presence of ab-
normal vascularity at the superior pole of the fossa ovalis. Incision was
made in the septum medial to the fossa ovalis, and when the left atrium
was entered, the incision was extended 360 around the tumor attachment.
Very small margins of the normal septal tissue were maintained, with almost
no direct instrument contact with the tumor when it was villous (Figure 4).
Four right atrial myxoms were completely resected from the beating heart
with the superior and inferior venae cavae snared. All tumors were grasped
by the tissue margins and deposited into an Endopouch Retriever (Ethicon
Endo-Surgery, Cincinnati, Ohio) and extracted via the working port. The
chamber was carefully inspected with the endoscope. Atrial septal defects
were repaired with autologous pericardial patches with 4-0 polytetrafluoro-
ethylene (Gore-Tex suture; W. L. Gore & Associates, Inc, Flagstaff, Ariz)
running suture in 2 patients via a right atriotomy and closed directly with
4-0 polytetrafluoroethylene running suture in 4 patients via a left atriotomy.
For posterior myxomas, the subendocardial defects were also directly closed
with 4-0 polytetrafluoroethylene running suture without pericardial patches,
and the septa of the remaining cases were intact. The atriotomy was closed
with 4-0 polytetrafluoroethylene running suture. After crossclamp release
and meticulous intracardiac deairing by angiocatheter of antegrade cold
blood cardioplegic solution, the patient was weaned from CPB. After re-
moval of the cardioplegia angioscope, the cardioplegia site was closed
with extracorporeal knot tying through the working port, and then chest
tubes were inserted. Integrity of the septal closure was confirmed by TEE.
Data are shown as mean  standard error of the mean.
RESULTS
All patients had successful resection of left atrial myxo-
mas with the da Vinci S Surgical System and were operated
on by the same console surgeon and patient-side surgeon.
The mean CPB and aortic crossclamp times were 98 
20.5 and 45 11.9 minutes, respectively. Total length of in-The Journal of Thoracic and Cartensive care unit stay for patients was 0.5 to 1.5 days. The
length of hospital stay for all patients was 5 to 7 days. The
postrepair intraoperative and follow-up TEE showed re-
moval of all tumors and no residual interatrial shunt. Patho-
logic examination revealed polypoid myxomas in 7 patients
and villous myxomas in 12 patients.
There were no operative deaths, strokes, or other compli-
cations. All procedures that were started with the da Vinci
Surgical System were completed with robotic assistance.
All the patients were discharged, and cosmetic results
were excellent in all cases (Figure 5). Patient follow-up
was performed to obtain clinical and echocardiographic
status. No recurrences of the tumor or septal leakage were
found. The clinical results were excellent. The follow-up
was 1 to 18 months and was 100% complete.DISCUSSION
Minimally invasive approaches are being applied with in-
creasing frequency in all areas of cardiac surgery, and car-
diac tumors are no exception. Experience is confined to
benign tumors and is quite limited. Approaches have in-
cluded right parasteral or partial sternotomy exposure with
standard cardioplegic techniques,12 right submammary inci-
sion with femoral–femoral bypass and nonclamped ventric-
ular fibrillation,13 and right submammary port-access
method with antegrade cardioplegia and ascending aortic
balloon occlusion.14
Over the past few years, computerized surgical robotic
systems have been developed very rapidly. The da Vinci sur-
gical robot has assisted the surgeon’s work using telemani-
pulation through a master-controller activation principle
with a 3-dimensional intracardiac camera. Chitwood15
showed that endoscopic mitral valve surgery could be per-
formed safely and with ‘‘gold standard’’ results. Surgical
telemanipulation seems an ideal method for operating accu-
rately through small incisions and in restricted spaces. In
fact, robotic technology can provide many potential benefitsdiovascular Surgery c Volume 139, Number 5 1283
FIGURE 2. Exposure of left atrial myxomas with the atrial retractor. FIGURE 3. Total excision by dissecting a plane through the atrial muscle
at the point of attachment.
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be smaller because of improved optics and instrumentation.
Our working port was only 1.5 cm9 (Figure 1). Wristlike
articulations transfer the dexterous actions of instrument
tips to the plane of intracardiac procedures. With the addi-
tion of tremor filtration, there is improved precision in tight
intracardiac spaces. Moreover, ambidexterity can become
a reality for all surgeons.
In 2005, Murphy and associates16 reported the initial suc-
cessful experience with left atrial myxoma excision with the
da Vinci Surgical System. We have not found other reports
about approaches for good exposure and ideal resection of
left or right atrial myxomas with the da Vinci S Surgical
System.
The surgical principles of myxoma excision include expo-
sure of the attachment point of the tumor, allowing excisionFIGURE 4. Almost no direct instrument contact with the tumor when it
was villous.
1284 The Journal of Thoracic and Cardiovascular Surof adequate tissue margins, removal of the tumor without
fragmentation, reconstruction of atrial wall defects, and the
ability to inspect the cardiac chambers for other tumors.17
We believed that exposure of left atrial myxomas was max-
imized by using several principles from mitral valve repair
surgery with atrial retractors (Figure 2). We desired the right
side of the heart to rotate up and the left side of the heart to
rotate down. Therefore, stay sutures were placed low on the
pericardium on the right side. This rotated the heart for
optimal exposure of the left atrium. For left atrial tumors,
the superior vena cava was extensively mobilized as was
the inferior vena cava–right atrial junction, allowing
increased mobility and exposing the left atrial cavity. Left
atrial myxomas could be approached by an incision throughFIGURE 5. Cosmetic results were excellent.
gery c May 2010
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nary veins. This incision could be extended behind both
cavae for greater exposure. Right atrial myxomas could be
resected directly through the right atrial incision from the
beating heart without an aortic crossclamp.
The atrial retractor (Intuitive) is an excellent device for
atrial exposure by the fourth arm (Figure 2). We believe
that this device offers superior identification of the tumor at-
tachment points to those that have been achieved in patients
in whom the surgical approach has been via median sternot-
omy. Furthermore, left atrial myxomas can be approached
more easily by the left atrial approach than the right; thus
the stalk can be easily found and total excision can be
achieved by dissecting a plane through the atrial muscle at
the point of attachment with 103 magnification (Figure 3).
Eleven of our 15 patients with left atrial myxoma were oper-
ated on through the left atrial approach.
Regardless of the surgical approach, the ideal resection
encompasses the tumor and a portion of the cardiac wall or
interatrial septum to which it is attached. Whether excision
of full-thickness wall is necessary or excision of only an
endocardial attachment is sufficient to prevent recurrence is
controversial.18 Our policy was to resect full thickness when-
ever possible. When the stalk of myxoma originated in the
septum, we tried to resect the stalk together with full septum,
and the septumwas then repaired. Actis Dato,19McCarthy,20
and their associates reported that only partial thickness resec-
tion of the area of tumor attachment was performed when an-
atomically necessary without a noted increase in recurrence
rate. In our study, we found that some stalks of myxoma
were loosely attached to the endocardium, which could be
easily resected robotically because of the 103magnification.
When the base/stalk of the myxomas was not completely
resected when anatomically necessary, we cauterized the
base of the myxomas to prevent recurrence.
Chitwood’s aortic clamp technique4 is safe, simple, and
economical compared with the remote access perfusion can-
nula with endoaortic balloon. In our group, aortic occlusion
was completed with the Chitwood crossclamp via the fourth
ICS in the midaxillary line. Cardioplegic solution adminis-
tered antegradely directly through the anterior chest wall
was feasible and safe.10 Therefore, the working port could
become smaller. In our series, the robotic system performed
safely and efficiently, with no operative deaths or conver-
sions resulting from a system malfunction. Only 2 patients
had temporary atrial fibrillation. Mean length of hospital
stay was shorter than that with conventional surgical repair.
These patients benefited from minimal trauma, early dis-
charge, and excellent cosmesis.
Limitations include longer follow-up to determine
whether the tumor recurs or not with the technique of partialThe Journal of Thoracic and Carthickness resection of the area of tumor attachment and
whether the intracardiac or intramediasdinal tumor spills
or not by removing the tumor in total with the endopouch
and a no-touch technique.
With limited cases, we conclude that the left atrial ap-
proach allows satisfactory exposure and ideal excision of
left atrial myxomas and that right atrial myxomas can be
completely resected with the heart beating. Excision of atrial
myxomas with the da Vinci S Surgical System is feasible,
efficacious, and safe. Surgical results are excellent.
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